Safety and Clinical Outcomes of Ipilimumab and Nivolumab Plus Concurrent Stereotactic Radiosurgery for Brain Metastases

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2018.07.778
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Preoperative Stereotactic Radiosurgery for Brain Metastases

Frontiers in Neurology
Neurology
2018English

Stereotactic Radiosurgery for Intraventricular Brain Metastases

Journal of Neurosurgery
SurgeryNeurology
2014English

Second Course of Stereotactic Radiosurgery for Locally Recurrent Brain Metastases: Safety and Efficacy

PLoS ONE
Multidisciplinary
2018English

Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With Greater Than 4 Brain Metastases

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Why Hypofractionate Stereotactic Radiosurgery for Brain Metastases?

CNS oncology
Medicine
2016English

MA08.11 Early Safety Data of a Phase I/Ii Combining Nivolumab and Stereotactic Brain Radiosurgery for Treatment of Brain Metastases in Patients With NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Pro-Inflammatory State Portends Poor Outcomes With Stereotactic Radiosurgery for Brain Metastases

Anticancer Research
MedicineCancer ResearchOncology
2016English

Stereotactic Radiosurgery for Brain Metastases: Analysis of Outcome and Risk of Brain Radionecrosis

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2011English

Postoperative Stereotactic Radiosurgery for Resected Brain Metastases: A Comparison of Outcomes for Large Resection Cavities

Practical Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy